My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

    Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P.

    Diabetes Care. 2009 Sep;32(9):1684-8. Epub 2009 Jun 5.PMID: 19502542 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.

    Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.

    Diabetes Care. 2005 Nov;28(11):2728-32.PMID: 16249547 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.

    Poulsen PL, Ebbehøj E, Mogensen CE.

    J Intern Med. 2001 May;249(5):433-40.PMID: 11350567 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.

    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.

    Afr J Med Med Sci. 2002 Mar;31(1):53-7.PMID: 12518931 [PubMed - indexed for MEDLINE]Related articles

    6.

    Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.

    Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.

    Diabetologia. 2009 Jan;52(1):46-9. Epub 2008 Oct 31.PMID: 18974967 [PubMed - indexed for MEDLINE]Related articles

    7.

    YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

    Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.

    Diabetes Care. 2009 Feb;32(2):323-8. Epub 2008 Oct 28.PMID: 18957531 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.

    Nishimura M, Sasaki T, Ohishi A, Oishi M, Kono S, Totani Y, Kato Y, Noto Y, Misaki S, Higashi K, Shimada F, Wakasugi H, Inoue K, Hoshiyama Y, Yamada K.

    Clin Nephrol. 2001 Aug;56(2):96-103.PMID: 11522101 [PubMed - indexed for MEDLINE]Related articles

    9.

    Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.

    Poulsen PL, Ebbehøj E, Nosadini R, Fioretto P, Deferrari G, Crepaldi G, Mogensen CE.

    Diabetes Metab. 2001 Apr;27(2 Pt 1):123-8.PMID: 11353877 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

    Diabetes Care. 2000 Dec;23(12):1725-30.PMID: 11128341 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.

    Harmankaya O, Seber S, Yilmaz M.

    Ren Fail. 2003 May;25(3):465-70.PMID: 12803510 [PubMed - indexed for MEDLINE]Related articles

    12.

    Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.

    Diabetes Care. 2003 Sep;26(9):2632-6.PMID: 12941731 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.

    [No authors listed]

    Lancet. 1997 Jun 21;349(9068):1787-92.PMID: 9269212 [PubMed - indexed for MEDLINE]Related articles

    14.

    Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.

    Gambaro G, Kinalska I, Oksa A, Pont'uch P, Hertlová M, Olsovsky J, Manitius J, Fedele D, Czekalski S, Perusicová J, Skrha J, Taton J, Grzeszczak W, Crepaldi G.

    J Am Soc Nephrol. 2002 Jun;13(6):1615-25.PMID: 12039991 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.

    Diabetes. 1997 Mar;46(3):481-7.PMID: 9032106 [PubMed - indexed for MEDLINE]Related articles

    16.

    Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

    Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

    Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

    Kidney Int. 2000 Feb;57(2):590-600.PMID: 10652036 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.

    O'Hare P, Bilbous R, Mitchell T, O' Callaghan CJ, Viberti GC; Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group.

    Diabetes Care. 2000 Dec;23(12):1823-9.PMID: 11128360 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.

    Agardh CD, Agardh E, Torffvit O.

    Diabetes Res Clin Pract. 1997 Mar;35(2-3):113-21.PMID: 9179466 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.

    Ann Intern Med. 1998 Jun 15;128(12 Pt 1):982-8.PMID: 9625684 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity